Alfuzosin

Alfuzosin is a prescription medication used for treating the symptoms of benign prostatic hyperplasia.

• Alfuzosin is available under the following different brand names: Alfutral, UroXatral, Xatral

Adult dosage

Tablet, extended-release

• 10mg

Benign Prostatic Hyperplasia (BPH)

Adult and geriatric dosage

• 10 mg orally every day, taken after the same meal

Dosage Considerations – Should be Given as Follows: 

• See “Dosages”

Common side effects of Alfuzosin include:

• dizziness,
• lightheadedness,
• headache,
• fatigue,
• tired feeling, or
• cold symptoms such as stuffy nose, sneezing, or sore throat.

Serious side effects of Alfuzosin include:

• severe dizziness,
• fainting,
• fast/irregular heartbeat, or
• chest pain.

Rare side effects of Alfuzosin include:

• none 

This is not a complete list of side effects and other serious side effects or health problems that may occur as a result of the use of this drug. Call your doctor for medical advice about serious side effects or adverse reactions. You may report side effects or health problems to FDA at 1-800-FDA-1088.

If your medical doctor is using this medicine to treat your pain, your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with your doctor, health care provider, or pharmacist first.

• Alfuzosin has severe interactions with at least 30 other drugs.
• Alfuzosin has serious interactions with at least 80 other drugs.
• Alfuzosin has moderate interactions with at least 234 other drugs.
• Alfuzosin has minor interactions with at least 54 other drugs.

This information does not contain all possible interactions or adverse effects. Visit the RxList Drug Interaction Checker for any drug interactions. Therefore, before using this product, tell your doctor or pharmacist about all the products you use. Keep a list of all your medications with you and share this information with your doctor and pharmacist. Check with your health care professional or doctor for additional medical advice, or if you have health questions or concerns.

Contraindications

• Hypersensitivity
• Moderate to severe liver impairment
• Coadministration with potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir) or other alpha1-blocking agents

Effects of drug abuse

• None

Short-Term Effects

• See “What Are Side Effects Associated with Using Alfuzosin?”

Long-Term Effects

• See “What Are Side Effects Associated with Using Alfuzosin?”

Cautions

• Caution in coronary artery disease, liver disease, symptomatic orthostatic hypotension, or coadministration with other drugs that lower blood pressure
• May cause syncope (first-dose effect)
• Discontinue treatment if angina occurs or worsens
• Rule out prostate cancer before initiating therapy (symptoms similar)
• Priapism may occur with the use
• Rule out prostate cancer before the  treatment
• Caution with renal impairment (e.g., CrCl below 30 mL/min)
• Caution with history of prolonged QT syndrome (shown to prolong QT interval)
• Intraoperative floppy iris syndrome during cataract surgery reported Advise patient regarding the risk of priapism
• Do not chew or crush tablets
• Not for use as an antihypertensive drug

Pregnancy and Lactation

• The drug is not indicated for use in women; there are no adequate data on the developmental risk associated with use in pregnant women
• Lactation
  • The drug is not indicated for use in women; there are no data on its presence in human milk, its effect on the breastfed child, or milk production